Liquefy and transport bronchial mucus, even from the very distal parts of the lungs

No increase of the patient fatigue

Reduced risk of bronchial collapsus

No side effect, very few contraindications

Safe and easy to handle / Easy to learn

Hygienic concept with exhalation-kit replacement

Has ergonomics for being used by the patient himself (autonomy in airway clearance management) or in addition to the physiotherapist s intervention

Improvement of lung function characteristics such as FEV1 and FVC 1, 2

Improvement of the quality of life in COPD and Bronchiectasis as assessed by the CAT score 1, 2

Improvement of exercise capacity in Bronchiectasis, as assessed by 6MWT 1

Improved symptoms1, 2 and secretion clearance 3

High subjective effectiveness in Simeox performance vs. conventional physiotherapy 3

1 Benets of Simeox airway clearance technology in non-CF patients with bronchiectasis, Iwan et al., ERJ September 2018, 52 (Supplement 62) 2 Eects of a new Airway Clearance Technology versus manual physiotherapy in COPD, Mihaltan et al., ERJ September 2018, 52 (Supplement 62) 3 SIMETOL clinical study report, November 2018

Product benefits

Clinical outcomes

contact@physio-assist.com www.physioassist.com

Tel : +33 (0)4 67 03 13 92

PhysioAssist

31 Parc du Golf - CS 90519 13593 Aix-en-Provence Cedex 3 OP

S_ EN

01 _1

11 8

0459

This class IIa medical device is a regulated healthcare product that carries, under these regulations, the CE marking

Read the instructions in the user manual carefully before using the device.